Eugene, ORNCT06093672Now EnrollingIRB Ready

Polycythemia Vera Clinical Trial in Eugene, OR

Access cutting-edge polycythemia vera treatment through this clinical trial at a research site in Eugene. Study-provided care at no cost to qualified participants.

Sponsored by Italfarmaco

Quick Self-Assessment

See if you qualify for this Eugene location

Preparing your pre-screening questions...

Expert Care in Eugene

Access polycythemia vera specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related polycythemia vera treatment provided free

Apply for This Eugene Location

Check if you qualify for this polycythemia vera clinical trial in Eugene, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Eugene

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Eugene site if eligible
  4. 4Begin participation

About This Polycythemia Vera Study in Eugene

The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.

Sponsor: Italfarmaco

Who Can Participate

Inclusion Criteria

Patients must have been diagnosed with PV according to the 2016 WHO criteria before randomization
Patients must have JAK2V617F-positive disease
Patients with PV must meet the definition of HR for thrombosis (i.e., HR) within 3 years before screening as follows:
Age ≥ 60 years, and/or
Prior thrombosis.
Patients must be in need of treatment at screening, defined by the presence of at least one of the following:
HCT ≥ 45% or HCT \< 45% with at least 1 phlebotomy performed in the 3 months before screening, or
WBC count \> 10 × 109/L, or
PLT count \> 400 × 109/L.
Patients must have normalized HCT (i.e., HCT \< 45%) at randomization Extended Treatment - Inclusion Criteria
Patients must have completed the Week 48 visit of the DSC/08/2357/32 core treatment phase and: 1. if the patient received givinostat, a complete hematological response (CHR) at Week 48 shall be achieved 2. if the patient received HU, did not achi

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Eugene?

Yes, this clinical trial (NCT06093672) has an active research site in Eugene, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Polycythemia Vera Treatment Options in Eugene, OR

If you're searching for polycythemia vera treatment options in Eugene, OR, this clinical trial (NCT06093672) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Eugene research site is actively enrolling participants for this clinical trial. You'll receive care from experienced polycythemia vera specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all polycythemia vera clinical trials near you to find additional studies recruiting in your area.

More Myeloproliferative Neoplasms Trials in Eugene, OR

See all myeloproliferative neoplasms clinical trials recruiting in Eugene — not just this study.

Browse Myeloproliferative Neoplasms Trials in Eugene →

Browse More Trials by Condition

Myeloproliferative Neoplasms TrialsHeart Attack TrialsRheumatoid Arthritis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Eugene?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Eugene, OR